Analysis of Torquetenovirus DNA levels in NSCLC patients treated with immune checkpoint inhibitors
Lilia Cinti, Lucrezia Tuosto, Piergiorgio Roberto, Roberta Campagna, Aurelia Rughetti, Chiara Napoletano, Alain J. Gelibter, Daniele Santini, Guido Antonelli, Ombretta Turriziani · 2026
Read Analysis of Torquetenovirus DNA levels in NSCLC patients treated with immune checkpoint inhibitors by Lilia Cinti, Lucrezia Tuosto, Piergiorgio Roberto, Roberta Campagna, Aurelia Rughetti, Chiara Napoletano, Alain J. Gelibter, Daniele Santini, Guido Antonelli, Ombretta Turriziani (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13178919.txt.
Description
A mild virus that lives in most adults ticks up when the immune guard is low, so its load can mirror immune strength. Lilia Cinti and co-authors test that mirror in 2026 in lung cancer patients on immune freeing drugs. They read virus load in blood for sixty four patients, at start and three months in.
At the start, patients ran higher loads than healthy givers, a sign of weak guard. After three months of care, loads fell to near healthy marks. The fall ran deeper in patients whose tumours shrank. The team reads the drop as a sign that immune strength came back. They call for big, long studies to firm the mark's worth.
Catalog record
| CREATOR | Lilia Cinti, Lucrezia Tuosto, Piergiorgio Roberto, Roberta Campagna, Aurelia Rughetti, Chiara Napoletano, Alain J. Gelibter, Daniele Santini, Guido Antonelli, Ombretta Turriziani |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 12 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |